These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 6074004

  • 1. Tyrosine metabolism in patients with liver disease.
    Levine RJ, Conn HO.
    J Clin Invest; 1967 Dec; 46(12):2012-20. PubMed ID: 6074004
    [Abstract] [Full Text] [Related]

  • 2. Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion.
    Tessari P, Kiwanuka E, Vettore M, Barazzoni R, Zanetti M, Cecchet D, Orlando R.
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G598-604. PubMed ID: 18653725
    [Abstract] [Full Text] [Related]

  • 3. Hepatic copper content, urinary copper excretion, and serum ceruloplasmin in liver disease.
    Ritland S, Steinnes E, Skrede S.
    Scand J Gastroenterol; 1977 Sep; 12(1):81-8. PubMed ID: 834974
    [Abstract] [Full Text] [Related]

  • 4. Validity of 13C-phenylalanine breath test to evaluate functional capacity of hepatocyte in patients with liver cirrhosis and acute hepatitis.
    Koeda N, Iwai M, Kato A, Suzuki K.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):851-9. PubMed ID: 15801920
    [Abstract] [Full Text] [Related]

  • 5. Impaired elimination of meperidine in patients with liver disease.
    McHorse TS, Klotz U, Wilkinson G, Schenker S.
    Trans Assoc Am Physicians; 1974 Apr 01; 87():281-7. PubMed ID: 4456737
    [No Abstract] [Full Text] [Related]

  • 6. Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis.
    Trevisani F, Bernardi M, Arienti V, Scrivano P, Mazziotti A, Cavallari A, Patrono D, Piazzi S, Gozzetti G, Gasbarrini G.
    Hepatology; 1994 Feb 01; 19(2):329-38. PubMed ID: 8294090
    [Abstract] [Full Text] [Related]

  • 7. Analysis of abnormal recovery pattern of liver function tests after surgical repair of bile duct strictures.
    Negi SS, Chaudhary A.
    J Gastroenterol Hepatol; 2005 Oct 01; 20(10):1533-7. PubMed ID: 16174070
    [Abstract] [Full Text] [Related]

  • 8. The "pseudo-cholangiocarcinoma sign" in patients with cavernous transformation of the portal vein and its effect on the serum alkaline phosphatase and bilirubin levels.
    Bayraktar Y, Balkanci F, Ozenc A, Arslan S, Koseoglu T, Ozdemir A, Uzunalimoglu B, Telatar H, Gurakar A, Van Thiel DH.
    Am J Gastroenterol; 1995 Nov 01; 90(11):2015-9. PubMed ID: 7485013
    [Abstract] [Full Text] [Related]

  • 9. The discriminatory ability of a galactose tolerance test and some other tests in the diagnosis of cirrhosis of the liver, hepatitis and biliary obstruction.
    Tengström B.
    Scand J Clin Lab Invest; 1969 Apr 01; 23(2):159-68. PubMed ID: 5372446
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinico-diagnostic significance of the determination of bile acids in chronic liver diseases].
    Andreuzzi B, Vai C, Santese R, Andreuzzi P, Cantoni L.
    Minerva Med; 1984 Mar 31; 75(13):749-56. PubMed ID: 6717831
    [Abstract] [Full Text] [Related]

  • 12. L-[1-(13)C] Phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease.
    Burke PA, Stack JA, Wagner D, Lewis DW, Jenkins RL, Forse RA.
    Am J Surg; 1997 Apr 31; 173(4):270-3; discussion 273-4. PubMed ID: 9136778
    [Abstract] [Full Text] [Related]

  • 13. The discriminant diagnostic power of liver function tests in hepatic cirrhosis.
    Serra MA, Rodrigo JM, Guix J, Montes F, Wassel A, Aparisi L, Olmo JA, Bixquert M.
    Acta Med Port; 1981 Apr 31; 3(1):3-10. PubMed ID: 7304266
    [No Abstract] [Full Text] [Related]

  • 14. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection.
    Giannini E, Botta F, Borro P, Malfatti F, Fumagalli A, Testa E, Podestà E, Chiarbonello B, Polegato S, Mamone M, Testa R.
    Am J Gastroenterol; 2003 Nov 31; 98(11):2516-20. PubMed ID: 14638357
    [Abstract] [Full Text] [Related]

  • 15. [Hepatic clearance of 99mTc-p-butyl HIDA in liver diseases. Correlations with routine hematochemical parameters of liver function].
    Custro N, De Francisci MC, Patanella I, Scafidi V, Indovina I.
    Minerva Med; 1984 Nov 03; 75(42):2527-32. PubMed ID: 6083507
    [Abstract] [Full Text] [Related]

  • 16. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
    Tietge UJ, Selberg O, Kreter A, Bahr MJ, Pirlich M, Burchert W, Müller MJ, Manns MP, Böker KH.
    Liver Transpl; 2004 Aug 03; 10(8):1030-40. PubMed ID: 15390330
    [Abstract] [Full Text] [Related]

  • 17. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
    Fasoli A, Giannini E, Botta F, Romagnoli P, Risso D, Celle G, Testa R.
    Hepatogastroenterology; 2000 Aug 03; 47(31):234-8. PubMed ID: 10690614
    [Abstract] [Full Text] [Related]

  • 18. [Plasma tyrosine level in liver diseases].
    Selmair H, Langness U, Zimmermann J, Herborn U.
    Med Klin; 1971 Jun 23; 66(30):1049-52. PubMed ID: 5569262
    [No Abstract] [Full Text] [Related]

  • 19. Natural history of hepatectomy regarding liver function: a study of both normal livers and livers with chronic hepatitis and cirrhosis.
    Ezaki T, Koyanagi N, Toyomasu T, Ikeda Y, Sugimachi K.
    Hepatogastroenterology; 1998 Jun 23; 45(23):1795-801. PubMed ID: 9840150
    [Abstract] [Full Text] [Related]

  • 20. Tyrosine metabolism in cirrhosis.
    Nordlinger BM, Fulenwider JT, Ivey GL, Faraj BA, Ali FM, Kutner M, Henderson JM, Rudman D.
    J Lab Clin Med; 1979 Dec 23; 94(6):832-40. PubMed ID: 501206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.